Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 18 Jun 2020 |
10 | Journal Copy | 09 Nov 2023 |
11 | Certificate | 05 Dec 2023 |
2 | Reply to Exam Report (MIS-R) | 02 Aug 2020 |
3 | Authorization Letter | 26 Oct 2021 |
4 | TM-M(EXTENSION OF TIME) | 20 Dec 2021 |
5 | Authorization Letter | 07 Feb 2022 |
6 | Authorization Letter | 06 Jul 2022 |
7 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 08 Sep 2022 |
8 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 02 Mar 2023 |
9 | Authorization Letter | 02 Mar 2023 |
1 | EXAMINATION REPORT | 10192626 | 21 Jul 2020 | |
2 | Hearing Notice (Show Cause) | 12068899 | 27 Aug 2021 | |
3 | Hearing Notice (Show Cause) | 12422508 | 05 Nov 2021 | |
4 | Hearing Notice (Show Cause) | 12774255 | 05 Jan 2022 | |
5 | Hearing Notice (Show Cause) | 13601171 | 06 Jun 2022 | |
6 | Hearing Notice (Show Cause) | 14614040 | 10 Jan 2023 | |
7 | Tribunal Accepted Notice for : 4536522 | 15512170 | 6029247 | 27 Jun 2023 |
The application for Koact was made on 18 June 2020.
The trademark applicant for Koact is AUROBINDO PHARMA.
Koact is applied in class(es) 5.
Application for Koact is on Registered stage.
Application Id allotted to Koact is 4536522.
Trademark agent or attorney for the application is Daswani & Daswani.
Koact filed with the Intellectual property office as a WORD.